A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2011
08/31/2011	CN102166280A Chinese medicinal composition for preventing and treating common cold and influenza and preparation method thereof
08/31/2011	CN102166275A Chinese herbal medicine for treating pulmonary diseases
08/31/2011	CN102166270A Oil-in-water type dried orange peel oil nano-emulsion and preparation method thereof
08/31/2011	CN102166268A Production method for improving drying of lung-heat-cleaning anti-inflammation water-honeyed pills
08/31/2011	CN102166257A Oil-in-water type cinnamon oil nano emulsion oral liquid
08/31/2011	CN102166245A Oil in water type blumea oil nanoemulsion and preparation method thereof
08/31/2011	CN102166242A Asarum oil nano emulsion and method for preparing same
08/31/2011	CN102166233A Oil-in-water type sea buckthorn oil nano-emulsion oral liquid and preparation method thereof
08/31/2011	CN102166226A Production process of posterior pituitary solution
08/31/2011	CN102166225A Snore stopping liquid and preparation process thereof
08/31/2011	CN102166220A Bacille calmette-guerin (BCG) immunosuppressant, and preparation method and application thereof
08/31/2011	CN102166217A Use of Bordetella pertussis CpG-ODNs (CpG oligodeoxynucleotides) as medicine for preventing and treating asthma
08/31/2011	CN102166215A Pharmaceutical composition containing piperazine derivatives
08/31/2011	CN102166213A Composition using levalbuterol and ipratropium bromide as active ingredients
08/31/2011	CN101926901B Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof
08/31/2011	CN101912365B Sulbenicillin sodium powder injection and preparation process thereof
08/31/2011	CN101829297B Traditional Chinese medicine composition for treating asthma and preparation method thereof
08/31/2011	CN101829267B Traditional Chinese medicine combination for treating lung asthma and preparation method thereof
08/31/2011	CN101829212B Buccal tablet and preparation method thereof
08/31/2011	CN101804097B Shiqin resuscitation-inducing paste and preparation method thereof
08/31/2011	CN101781373B Salbutamol modified guanidinated chitosan and preparation method and application thereof
08/31/2011	CN101766787B Enema liquid for treating hyperpyrexia and cough and asthma
08/31/2011	CN101690745B Chinese medicinal composition for preventing and treating flu
08/31/2011	CN101607032B Compound medicament for treating children cough and preparation method thereof
08/31/2011	CN101606964B Veterinary traditional Chinese medical compound preparation
08/31/2011	CN101584752B Extraction and purification process for total flavonoids in Anchusa italica Retiz
08/31/2011	CN101502528B Application of esculentoside A in preparing medicament for preventing or treating pulmonary fibrosis
08/31/2011	CN101428049B Upper respiratory tract infection resistant medicament composition, preparation and uses thereof
08/31/2011	CN101360709B Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR)
08/31/2011	CN101301385B Detection method of compound preserved snake gall orange peel powder
08/31/2011	CN101293054B Chinese Medicinal composition for treating kidney Qi deficiency
08/31/2011	CN101293015B Chinese medicinal composition, preparation method and application thereof
08/31/2011	CN101292692B Plant cold tea condensed juice, preparation and application thereof
08/31/2011	CN101181320B Dyer's woad root vitamin C effervescent formulation
08/30/2011	US8008483 sEH inhibitors and their use
08/30/2011	US8008341 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/30/2011	US8008278 Diarylmethyl and related compounds
08/30/2011	US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1
08/30/2011	US8007830 Oral granules of montelukast sodium; e.g. spray-dried mannitol coated with said drug; may be ingested directly or mixed with food or other comestibles for patients who have difficulty swallowing
08/30/2011	US8007817 Compositions and methods for treating microbial infections
08/30/2011	US8007799 Vascular endothelial cell growth factor antagonists and uses thereof
08/30/2011	US8007798 Treatment of complement-associated disorders
08/30/2011	CA2672373C Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
08/30/2011	CA2472293C Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
08/30/2011	CA2440473C Metalloproteinase inhibitors
08/30/2011	CA2438717C 6-phenylbenzonaphthyridines
08/30/2011	CA2393352C Adamantane derivatives
08/30/2011	CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines
08/30/2011	CA2251647C Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
08/25/2011	WO2011102483A1 HUMAN LAP TGF-β BINDING ANTIBODY
08/25/2011	WO2011102436A1 Tgf-β signal transduction inhibitor
08/25/2011	WO2011102404A1 Imidazole derivative
08/25/2011	WO2011080269A3 Pharmaceutical preparations comprising a cos releasing compound
08/25/2011	WO2011041461A3 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response
08/25/2011	US20110207783 Renin inhibitors
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207770 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207728 Compounds for treating respiratory syncytial virus infections
08/25/2011	US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207704 Novel Oxadiazole Compounds
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207655 Cyclic depsipeptide compound and use thereof
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206721 Fermented soy nutritional supplements including mushroom components
08/25/2011	US20110206686 Il-23 antibodies
08/25/2011	US20110206669 Mcp1 fusions
08/25/2011	US20110206668 Methods and compositions for modulating immunity
08/25/2011	DE102010008982A1 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie A silicon-containing biologically degradable material for anti-inflammatory therapy
08/25/2011	DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy
08/24/2011	EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2359869A2 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same and uses therefor
08/24/2011	EP2359858A1 Nutritional composition comprising indigestible oligosaccharides
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359845A1 Inhalant comprising modified superoxide dismutase
08/24/2011	EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011	EP2359826A1 Combination of HMG-COA reductase inhibitors, such as roflumilast, roflumilast-N-oxide with a phosphodiesterase 4 inhibitor, rosuvastatin, for the treatment of inflammatory pulmonary diseases
08/24/2011	EP2358754A1 Ligands that bind il-13
08/24/2011	EP2358740A1 Cyclic peptides and uses thereof
08/24/2011	EP2358724A1 Tiotropium bromide having a low degree of crystallinity
08/24/2011	EP2358721A1 Modulators of cystic fibrosis transmembrane conductance regulator
08/24/2011	EP2358692A1 Cysteine protease inhibitors
08/24/2011	EP2358688A2 Antagonists of lysophosphatidic acid receptors
08/24/2011	EP2358680A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
08/24/2011	EP2358677A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
08/24/2011	EP1951687B1 N-hydroxyamide derivatives and use thereof
08/24/2011	EP1831208B1 Quaternary ammonium salts as m3 antagonists
08/24/2011	EP1755590B1 Combination of glycopyrrolate and a beta2 adrenoceptor agonist
08/24/2011	EP1571155B1 Peptides and medicinal compositions containing the same
08/24/2011	EP1499729B1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
08/24/2011	EP1485353B1 New inhibitors of histone deacetylase
08/24/2011	EP1480962B1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
08/24/2011	EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases
08/24/2011	EP1259544B1 Heterologous polypeptide of the tnf family

1 ... 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... 878